David Erlinge and Dr. C Michael Gibson Discuss: INFINITY-SWEDEHEART Complex PCI1-Year and Landmark 6–12 Month Clinical Outcomes Among Patients With Complex Lesion Subsets Treated with DynamX Bioadaptor Compared to a Contemporary Drug Eluting Stent October 28, 2024 2024 | Cardiology | Slides | TCT | Trial | Video David ErlingeINFINITY-SWEDEHEART TCT LBCS presentation slidesDownload Disclosures: TBD Article Navigation Marc Dweck and Dr. C Michael Gibson Discuss: EVOLVEDEarly Intervention in Patients With Asymptomatic Severe Aortic Stenosis and Left Ventricular Myocardial Fibrosis Alexander Van Rosendael and Dr. C Michael Gibson Discuss: CONFIRM-2Artificial Intelligence Enabled Quantitative CT Assessment of Atherosclerosis and Major Adverse Events: A Multi-Center International Registry
